In Vitro Diagnostics (IVD): Infectious Disease
Infectious diseases are disorders that are caused by various organisms like bacteria, viruses, fungi or parasites. They are transmitted through contaminated foods and through physical contacts. Infectious diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), Herpes Simplex Virus (HSV), tuberculosis, measles, dengue, Chagas, cholera, and malaria are increasing across the globe, mostly in developing countries.
In Vitro Diagnostics (IVDs) help in identifying the pathogenic agent such as bacteria, viruses or fungi that are responsible infectious diseases and alo helps to select the appropriate treatment options. Molecular Diagnostics Tests also helps to perform both targeted and syndromic Clinical Tests for Infectious Diseases resulting the incresing demands.
As per a research it is found that the Global IVD Infectious Disease market is anticipated to hit $25.9bn by end of the year 2022. Major drivers of the IVD market for the Infectious Disease are launch of new advanced Diagnostics Devices, rapid growth of infectious disease, accuracy and cost effectiveness of the Diagnostics Devices etc.